|
Name |
Methyl isostearate
|
| Molecular Formula | C19H38O2 | |
| IUPAC Name* |
methyl 16-methylheptadecanoate
|
|
| SMILES |
CC(C)CCCCCCCCCCCCCCC(=O)OC
|
|
| InChI |
InChI=1S/C19H38O2/c1-18(2)16-14-12-10-8-6-4-5-7-9-11-13-15-17-19(20)21-3/h18H,4-17H2,1-3H3
|
|
| InChIKey |
KDQIFKKWPMBNOH-UHFFFAOYSA-N
|
|
| Synonyms |
Methyl isostearate; Methyl 16-methylheptadecanoate; 5129-61-3; 68517-10-2; Heptadecanoic acid, 16-methyl-, methyl ester; 16-Methylheptadecanoic acid methyl ester; 16-METHYLHEPTADECANOICACIDMETHYLESTER; 2B9VP4H2JC; EC 614-560-4; Isooctadecanoic acid, methyl ester; Isooctadecanoic acid,methyl ester; Methyl isooctadecanoate; UNII-2B9VP4H2JC; SCHEMBL8601185; DTXSID401027738; ZINC4557074; 16-Methylheptadecanoic acid-methyl ester; FT-0607253; Q63409252
|
|
| CAS | 5129-61-3 | |
| PubChem CID | 110444 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 298.5 | ALogp: | 8.7 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
| Heavy Atoms: | 21 | QED Weighted: | 0.263 |
| Caco-2 Permeability: | -4.751 | MDCK Permeability: | 0.00001340 |
| Pgp-inhibitor: | 0.022 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.951 |
| 30% Bioavailability (F30%): | 0.988 |
| Blood-Brain-Barrier Penetration (BBB): | 0.233 | Plasma Protein Binding (PPB): | 97.18% |
| Volume Distribution (VD): | 2.235 | Fu: | 1.64% |
| CYP1A2-inhibitor: | 0.245 | CYP1A2-substrate: | 0.195 |
| CYP2C19-inhibitor: | 0.409 | CYP2C19-substrate: | 0.121 |
| CYP2C9-inhibitor: | 0.222 | CYP2C9-substrate: | 0.97 |
| CYP2D6-inhibitor: | 0.066 | CYP2D6-substrate: | 0.03 |
| CYP3A4-inhibitor: | 0.331 | CYP3A4-substrate: | 0.075 |
| Clearance (CL): | 5.19 | Half-life (T1/2): | 0.182 |
| hERG Blockers: | 0.177 | Human Hepatotoxicity (H-HT): | 0.031 |
| Drug-inuced Liver Injury (DILI): | 0.421 | AMES Toxicity: | 0.005 |
| Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.014 |
| Skin Sensitization: | 0.956 | Carcinogencity: | 0.053 |
| Eye Corrosion: | 0.941 | Eye Irritation: | 0.962 |
| Respiratory Toxicity: | 0.885 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001160 | ![]() |
0.949 | D07ILQ | ![]() |
0.545 | ||
| ENC001181 | ![]() |
0.908 | D0Z5SM | ![]() |
0.468 | ||
| ENC000548 | ![]() |
0.898 | D00FGR | ![]() |
0.441 | ||
| ENC001519 | ![]() |
0.847 | D0P1RL | ![]() |
0.429 | ||
| ENC000271 | ![]() |
0.794 | D00AOJ | ![]() |
0.416 | ||
| ENC001142 | ![]() |
0.769 | D0O1PH | ![]() |
0.404 | ||
| ENC000496 | ![]() |
0.758 | D0T9TJ | ![]() |
0.402 | ||
| ENC000489 | ![]() |
0.746 | D05ATI | ![]() |
0.395 | ||
| ENC000560 | ![]() |
0.746 | D0G2KD | ![]() |
0.375 | ||
| ENC000316 | ![]() |
0.735 | D00MLW | ![]() |
0.362 | ||